<?xml version="1.0" encoding="utf-8"?>
<uniprot xmlns="http://uniprot.org/uniprot" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://uniprot.org/uniprot http://www.uniprot.org/support/docs/uniprot.xsd">
<entry dataset="Swiss-Prot" created="1986-07-21" modified="2020-10-07" version="255">
<accession>P01106</accession>
<accession>A8WFE7</accession>
<accession>P01107</accession>
<accession>Q14026</accession>
<name>MYC_HUMAN</name>
<protein>
<recommendedName>
<fullName>Myc proto-oncogene protein</fullName>
</recommendedName>
<alternativeName>
<fullName>Class E basic helix-loop-helix protein 39</fullName>
<shortName>bHLHe39</shortName>
</alternativeName>
<alternativeName>
<fullName>Proto-oncogene c-Myc</fullName>
</alternativeName>
<alternativeName>
<fullName>Transcription factor p64</fullName>
</alternativeName>
</protein>
<gene>
<name type="primary">MYC</name>
<name type="synonym">BHLHE39</name>
</gene>
<organism>
<name type="scientific">Homo sapiens</name>
<name type="common">Human</name>
<dbReference type="NCBI Taxonomy" id="9606"/>
<lineage>
<taxon>Eukaryota</taxon>
<taxon>Metazoa</taxon>
<taxon>Chordata</taxon>
<taxon>Craniata</taxon>
<taxon>Vertebrata</taxon>
<taxon>Euteleostomi</taxon>
<taxon>Mammalia</taxon>
<taxon>Eutheria</taxon>
<taxon>Euarchontoglires</taxon>
<taxon>Primates</taxon>
<taxon>Haplorrhini</taxon>
<taxon>Catarrhini</taxon>
<taxon>Hominidae</taxon>
<taxon>Homo</taxon>
</lineage>
</organism>
<reference key="1">
<citation type="journal article" date="1983" name="Cell" volume="34" first="779" last="787">
<title>The human c-myc oncogene: structural consequences of translocation into the IgH locus in Burkitt lymphoma.</title>
<authorList>
<person name="Battey J."/>
<person name="Moulding C."/>
<person name="Taub R."/>
<person name="Murphy W."/>
<person name="Stewart T."/>
<person name="Potter H."/>
<person name="Lenoir G."/>
<person name="Leder P."/>
</authorList>
<dbReference type="PubMed" id="6414718"/>
<dbReference type="DOI" id="10.1016/0092-8674(83)90534-2"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [GENOMIC DNA]</scope>
<scope>ALTERNATIVE SPLICING (ISOFORM 1)</scope>
</reference>
<reference key="2">
<citation type="journal article" date="1983" name="EMBO J." volume="2" first="2375" last="2383">
<title>Sequence of the murine and human cellular myc oncogenes and two modes of myc transcription resulting from chromosome translocation in B lymphoid tumours.</title>
<authorList>
<person name="Bernard O."/>
<person name="Cory S."/>
<person name="Gerondakis S."/>
<person name="Webb E."/>
<person name="Adams J.M."/>
</authorList>
<dbReference type="PubMed" id="6321164"/>
<dbReference type="DOI" id="10.1002/j.1460-2075.1983.tb01749.x"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [GENOMIC DNA]</scope>
<scope>ALTERNATIVE SPLICING (ISOFORM 1)</scope>
</reference>
<reference key="3">
<citation type="journal article" date="1983" name="Nature" volume="301" first="722" last="725">
<title>Identification and nucleotide sequence of a human locus homologous to the v-myc oncogene of avian myelocytomatosis virus MC29.</title>
<authorList>
<person name="Colby W.W."/>
<person name="Chen E.Y."/>
<person name="Smith D.H."/>
<person name="Levinson A.D."/>
</authorList>
<dbReference type="PubMed" id="6298632"/>
<dbReference type="DOI" id="10.1038/301722a0"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [GENOMIC DNA]</scope>
<scope>ALTERNATIVE SPLICING (ISOFORM 1)</scope>
</reference>
<reference key="4">
<citation type="journal article" date="1983" name="Nature" volume="303" first="725" last="728">
<title>Nucleotide sequence of cloned cDNA of human c-myc oncogene.</title>
<authorList>
<person name="Watt R."/>
<person name="Stanton L.W."/>
<person name="Marcu K.B."/>
<person name="Gallo R.C."/>
<person name="Croce C.M."/>
<person name="Rovera G."/>
</authorList>
<dbReference type="PubMed" id="6304538"/>
<dbReference type="DOI" id="10.1038/303725a0"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1)</scope>
</reference>
<reference key="5">
<citation type="journal article" date="1983" name="Nature" volume="306" first="760" last="765">
<title>Altered nucleotide sequences of a translocated c-myc gene in Burkitt lymphoma.</title>
<authorList>
<person name="Rabbitts T.H."/>
<person name="Hamlyn P.H."/>
<person name="Baer R."/>
</authorList>
<dbReference type="PubMed" id="6419122"/>
<dbReference type="DOI" id="10.1038/306760a0"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1)</scope>
<scope>VARIANT ASP-39</scope>
</reference>
<reference key="6">
<citation type="journal article" date="1983" name="Proc. Natl. Acad. Sci. U.S.A." volume="80" first="3642" last="3645">
<title>Nucleotide sequence analysis of human c-myc locus, chicken homologue, and myelocytomatosis virus MC29 transforming gene reveals a highly conserved gene product.</title>
<authorList>
<person name="Watson D.K."/>
<person name="Psallidopoulos M.C."/>
<person name="Samuel K.P."/>
<person name="Dalla-Favera R."/>
<person name="Papas T.S."/>
</authorList>
<dbReference type="PubMed" id="6304729"/>
<dbReference type="DOI" id="10.1073/pnas.80.12.3642"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [GENOMIC DNA]</scope>
<scope>ALTERNATIVE SPLICING (ISOFORM 1)</scope>
</reference>
<reference key="7">
<citation type="journal article" date="1984" name="Nature" volume="309" first="592" last="597">
<title>Effect of somatic mutation within translocated c-myc genes in Burkitt's lymphoma.</title>
<authorList>
<person name="Rabbitts T.H."/>
<person name="Forster A."/>
<person name="Hamlyn P."/>
<person name="Baer R."/>
</authorList>
<dbReference type="PubMed" id="6547209"/>
<dbReference type="DOI" id="10.1038/309592a0"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1)</scope>
<scope>NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 1-252</scope>
</reference>
<reference key="8">
<citation type="journal article" date="1984" name="EMBO J." volume="3" first="383" last="387">
<title>Nucleotide sequence of the human c-myc locus: provocative open reading frame within the first exon.</title>
<authorList>
<person name="Gazin C."/>
<person name="Dupont S."/>
<person name="de Dinechin D."/>
<person name="Hampe A."/>
<person name="Masson J.-M."/>
<person name="Martin P."/>
<person name="Stehelin D."/>
<person name="Galibert F."/>
</authorList>
<dbReference type="PubMed" id="6714223"/>
<dbReference type="DOI" id="10.1002/j.1460-2075.1984.tb01816.x"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [GENOMIC DNA]</scope>
<scope>ALTERNATIVE SPLICING (ISOFORM 1)</scope>
</reference>
<reference key="9">
<citation type="journal article" date="1993" name="Gene" volume="124" first="231" last="237">
<title>Allele-specific activation of the c-myc gene in an atypical Burkitt's lymphoma carrying the t(2;8) chromosomal translocation 250 kb downstream from c-myc.</title>
<authorList>
<person name="Tachibana K."/>
<person name="Takayama N."/>
<person name="Matsuo K."/>
<person name="Kato S."/>
<person name="Yamamoto K."/>
<person name="Ohyama K."/>
<person name="Umezawa A."/>
<person name="Takano T."/>
</authorList>
<dbReference type="PubMed" id="8444346"/>
<dbReference type="DOI" id="10.1016/0378-1119(93)90398-m"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [GENOMIC DNA]</scope>
<scope>ALTERNATIVE SPLICING (ISOFORMS 1 AND 2)</scope>
</reference>
<reference key="10">
<citation type="submission" date="2003-05" db="EMBL/GenBank/DDBJ databases">
<title>Cloning of human full-length CDSs in BD Creator(TM) system donor vector.</title>
<authorList>
<person name="Kalnine N."/>
<person name="Chen X."/>
<person name="Rolfs A."/>
<person name="Halleck A."/>
<person name="Hines L."/>
<person name="Eisenstein S."/>
<person name="Koundinya M."/>
<person name="Raphael J."/>
<person name="Moreira D."/>
<person name="Kelley T."/>
<person name="LaBaer J."/>
<person name="Lin Y."/>
<person name="Phelan M."/>
<person name="Farmer A."/>
</authorList>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1)</scope>
</reference>
<reference key="11">
<citation type="submission" date="2003-01" db="EMBL/GenBank/DDBJ databases">
<authorList>
<consortium name="NIEHS SNPs program"/>
</authorList>
</citation>
<scope>NUCLEOTIDE SEQUENCE [GENOMIC DNA]</scope>
<scope>VARIANTS SER-11; CYS-160; ILE-170 AND VAL-322</scope>
</reference>
<reference key="12">
<citation type="journal article" date="2004" name="Nat. Genet." volume="36" first="40" last="45">
<title>Complete sequencing and characterization of 21,243 full-length human cDNAs.</title>
<authorList>
<person name="Ota T."/>
<person name="Suzuki Y."/>
<person name="Nishikawa T."/>
<person name="Otsuki T."/>
<person name="Sugiyama T."/>
<person name="Irie R."/>
<person name="Wakamatsu A."/>
<person name="Hayashi K."/>
<person name="Sato H."/>
<person name="Nagai K."/>
<person name="Kimura K."/>
<person name="Makita H."/>
<person name="Sekine M."/>
<person name="Obayashi M."/>
<person name="Nishi T."/>
<person name="Shibahara T."/>
<person name="Tanaka T."/>
<person name="Ishii S."/>
<person name="Yamamoto J."/>
<person name="Saito K."/>
<person name="Kawai Y."/>
<person name="Isono Y."/>
<person name="Nakamura Y."/>
<person name="Nagahari K."/>
<person name="Murakami K."/>
<person name="Yasuda T."/>
<person name="Iwayanagi T."/>
<person name="Wagatsuma M."/>
<person name="Shiratori A."/>
<person name="Sudo H."/>
<person name="Hosoiri T."/>
<person name="Kaku Y."/>
<person name="Kodaira H."/>
<person name="Kondo H."/>
<person name="Sugawara M."/>
<person name="Takahashi M."/>
<person name="Kanda K."/>
<person name="Yokoi T."/>
<person name="Furuya T."/>
<person name="Kikkawa E."/>
<person name="Omura Y."/>
<person name="Abe K."/>
<person name="Kamihara K."/>
<person name="Katsuta N."/>
<person name="Sato K."/>
<person name="Tanikawa M."/>
<person name="Yamazaki M."/>
<person name="Ninomiya K."/>
<person name="Ishibashi T."/>
<person name="Yamashita H."/>
<person name="Murakawa K."/>
<person name="Fujimori K."/>
<person name="Tanai H."/>
<person name="Kimata M."/>
<person name="Watanabe M."/>
<person name="Hiraoka S."/>
<person name="Chiba Y."/>
<person name="Ishida S."/>
<person name="Ono Y."/>
<person name="Takiguchi S."/>
<person name="Watanabe S."/>
<person name="Yosida M."/>
<person name="Hotuta T."/>
<person name="Kusano J."/>
<person name="Kanehori K."/>
<person name="Takahashi-Fujii A."/>
<person name="Hara H."/>
<person name="Tanase T.-O."/>
<person name="Nomura Y."/>
<person name="Togiya S."/>
<person name="Komai F."/>
<person name="Hara R."/>
<person name="Takeuchi K."/>
<person name="Arita M."/>
<person name="Imose N."/>
<person name="Musashino K."/>
<person name="Yuuki H."/>
<person name="Oshima A."/>
<person name="Sasaki N."/>
<person name="Aotsuka S."/>
<person name="Yoshikawa Y."/>
<person name="Matsunawa H."/>
<person name="Ichihara T."/>
<person name="Shiohata N."/>
<person name="Sano S."/>
<person name="Moriya S."/>
<person name="Momiyama H."/>
<person name="Satoh N."/>
<person name="Takami S."/>
<person name="Terashima Y."/>
<person name="Suzuki O."/>
<person name="Nakagawa S."/>
<person name="Senoh A."/>
<person name="Mizoguchi H."/>
<person name="Goto Y."/>
<person name="Shimizu F."/>
<person name="Wakebe H."/>
<person name="Hishigaki H."/>
<person name="Watanabe T."/>
<person name="Sugiyama A."/>
<person name="Takemoto M."/>
<person name="Kawakami B."/>
<person name="Yamazaki M."/>
<person name="Watanabe K."/>
<person name="Kumagai A."/>
<person name="Itakura S."/>
<person name="Fukuzumi Y."/>
<person name="Fujimori Y."/>
<person name="Komiyama M."/>
<person name="Tashiro H."/>
<person name="Tanigami A."/>
<person name="Fujiwara T."/>
<person name="Ono T."/>
<person name="Yamada K."/>
<person name="Fujii Y."/>
<person name="Ozaki K."/>
<person name="Hirao M."/>
<person name="Ohmori Y."/>
<person name="Kawabata A."/>
<person name="Hikiji T."/>
<person name="Kobatake N."/>
<person name="Inagaki H."/>
<person name="Ikema Y."/>
<person name="Okamoto S."/>
<person name="Okitani R."/>
<person name="Kawakami T."/>
<person name="Noguchi S."/>
<person name="Itoh T."/>
<person name="Shigeta K."/>
<person name="Senba T."/>
<person name="Matsumura K."/>
<person name="Nakajima Y."/>
<person name="Mizuno T."/>
<person name="Morinaga M."/>
<person name="Sasaki M."/>
<person name="Togashi T."/>
<person name="Oyama M."/>
<person name="Hata H."/>
<person name="Watanabe M."/>
<person name="Komatsu T."/>
<person name="Mizushima-Sugano J."/>
<person name="Satoh T."/>
<person name="Shirai Y."/>
<person name="Takahashi Y."/>
<person name="Nakagawa K."/>
<person name="Okumura K."/>
<person name="Nagase T."/>
<person name="Nomura N."/>
<person name="Kikuchi H."/>
<person name="Masuho Y."/>
<person name="Yamashita R."/>
<person name="Nakai K."/>
<person name="Yada T."/>
<person name="Nakamura Y."/>
<person name="Ohara O."/>
<person name="Isogai T."/>
<person name="Sugano S."/>
</authorList>
<dbReference type="PubMed" id="14702039"/>
<dbReference type="DOI" id="10.1038/ng1285"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1)</scope>
<source>
<tissue>Uterus</tissue>
</source>
</reference>
<reference key="13">
<citation type="journal article" date="2006" name="Nature" volume="439" first="331" last="335">
<title>DNA sequence and analysis of human chromosome 8.</title>
<authorList>
<person name="Nusbaum C."/>
<person name="Mikkelsen T.S."/>
<person name="Zody M.C."/>
<person name="Asakawa S."/>
<person name="Taudien S."/>
<person name="Garber M."/>
<person name="Kodira C.D."/>
<person name="Schueler M.G."/>
<person name="Shimizu A."/>
<person name="Whittaker C.A."/>
<person name="Chang J.L."/>
<person name="Cuomo C.A."/>
<person name="Dewar K."/>
<person name="FitzGerald M.G."/>
<person name="Yang X."/>
<person name="Allen N.R."/>
<person name="Anderson S."/>
<person name="Asakawa T."/>
<person name="Blechschmidt K."/>
<person name="Bloom T."/>
<person name="Borowsky M.L."/>
<person name="Butler J."/>
<person name="Cook A."/>
<person name="Corum B."/>
<person name="DeArellano K."/>
<person name="DeCaprio D."/>
<person name="Dooley K.T."/>
<person name="Dorris L. III"/>
<person name="Engels R."/>
<person name="Gloeckner G."/>
<person name="Hafez N."/>
<person name="Hagopian D.S."/>
<person name="Hall J.L."/>
<person name="Ishikawa S.K."/>
<person name="Jaffe D.B."/>
<person name="Kamat A."/>
<person name="Kudoh J."/>
<person name="Lehmann R."/>
<person name="Lokitsang T."/>
<person name="Macdonald P."/>
<person name="Major J.E."/>
<person name="Matthews C.D."/>
<person name="Mauceli E."/>
<person name="Menzel U."/>
<person name="Mihalev A.H."/>
<person name="Minoshima S."/>
<person name="Murayama Y."/>
<person name="Naylor J.W."/>
<person name="Nicol R."/>
<person name="Nguyen C."/>
<person name="O'Leary S.B."/>
<person name="O'Neill K."/>
<person name="Parker S.C.J."/>
<person name="Polley A."/>
<person name="Raymond C.K."/>
<person name="Reichwald K."/>
<person name="Rodriguez J."/>
<person name="Sasaki T."/>
<person name="Schilhabel M."/>
<person name="Siddiqui R."/>
<person name="Smith C.L."/>
<person name="Sneddon T.P."/>
<person name="Talamas J.A."/>
<person name="Tenzin P."/>
<person name="Topham K."/>
<person name="Venkataraman V."/>
<person name="Wen G."/>
<person name="Yamazaki S."/>
<person name="Young S.K."/>
<person name="Zeng Q."/>
<person name="Zimmer A.R."/>
<person name="Rosenthal A."/>
<person name="Birren B.W."/>
<person name="Platzer M."/>
<person name="Shimizu N."/>
<person name="Lander E.S."/>
</authorList>
<dbReference type="PubMed" id="16421571"/>
<dbReference type="DOI" id="10.1038/nature04406"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]</scope>
</reference>
<reference key="14">
<citation type="submission" date="2005-07" db="EMBL/GenBank/DDBJ databases">
<authorList>
<person name="Mural R.J."/>
<person name="Istrail S."/>
<person name="Sutton G.G."/>
<person name="Florea L."/>
<person name="Halpern A.L."/>
<person name="Mobarry C.M."/>
<person name="Lippert R."/>
<person name="Walenz B."/>
<person name="Shatkay H."/>
<person name="Dew I."/>
<person name="Miller J.R."/>
<person name="Flanigan M.J."/>
<person name="Edwards N.J."/>
<person name="Bolanos R."/>
<person name="Fasulo D."/>
<person name="Halldorsson B.V."/>
<person name="Hannenhalli S."/>
<person name="Turner R."/>
<person name="Yooseph S."/>
<person name="Lu F."/>
<person name="Nusskern D.R."/>
<person name="Shue B.C."/>
<person name="Zheng X.H."/>
<person name="Zhong F."/>
<person name="Delcher A.L."/>
<person name="Huson D.H."/>
<person name="Kravitz S.A."/>
<person name="Mouchard L."/>
<person name="Reinert K."/>
<person name="Remington K.A."/>
<person name="Clark A.G."/>
<person name="Waterman M.S."/>
<person name="Eichler E.E."/>
<person name="Adams M.D."/>
<person name="Hunkapiller M.W."/>
<person name="Myers E.W."/>
<person name="Venter J.C."/>
</authorList>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]</scope>
</reference>
<reference key="15">
<citation type="journal article" date="2004" name="Genome Res." volume="14" first="2121" last="2127">
<title>The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).</title>
<authorList>
<consortium name="The MGC Project Team"/>
</authorList>
<dbReference type="PubMed" id="15489334"/>
<dbReference type="DOI" id="10.1101/gr.2596504"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2)</scope>
<source>
<tissue>Cervix</tissue>
<tissue>Placenta</tissue>
<tissue>Testis</tissue>
</source>
</reference>
<reference key="16">
<citation type="journal article" date="1986" name="Mol. Cell. Biol." volume="6" first="3481" last="3489">
<title>Novel promoter upstream of the human c-myc gene and regulation of c-myc expression in B-cell lymphomas.</title>
<authorList>
<person name="Bentley D.L."/>
<person name="Groudine M."/>
</authorList>
<dbReference type="PubMed" id="3540591"/>
<dbReference type="DOI" id="10.1128/mcb.6.10.3481"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] OF 1-170 (ISOFORM 1)</scope>
<source>
<tissue>Promyelocytic leukemia</tissue>
</source>
</reference>
<reference key="17">
<citation type="journal article" date="1990" name="Adv. Cancer Res." volume="55" first="133" last="270">
<title>The pathogenesis of Burkitt's lymphoma.</title>
<authorList>
<person name="Magrath I."/>
</authorList>
<dbReference type="PubMed" id="2166998"/>
<dbReference type="DOI" id="10.1016/s0065-230x(08)60470-4"/>
</citation>
<scope>INVOLVEMENT IN BURKITT LYMPHOMA</scope>
</reference>
<reference key="18">
<citation type="journal article" date="1992" name="Eur. J. Biochem." volume="206" first="595" last="603">
<title>DNA-activated protein kinase in Raji Burkitt's lymphoma cells. Phosphorylation of c-Myc oncoprotein.</title>
<authorList>
<person name="Iijima S."/>
<person name="Teraoka H."/>
<person name="Date T."/>
<person name="Tsukada K."/>
</authorList>
<dbReference type="PubMed" id="1597196"/>
<dbReference type="DOI" id="10.1111/j.1432-1033.1992.tb16964.x"/>
</citation>
<scope>PHOSPHORYLATION</scope>
</reference>
<reference key="19">
<citation type="journal article" date="1993" name="Nat. Genet." volume="5" first="56" last="61">
<title>Point mutations in the c-Myc transactivation domain are common in Burkitt's lymphoma and mouse plasmacytomas.</title>
<authorList>
<person name="Bhatia K."/>
<person name="Huppi K."/>
<person name="Spangler G."/>
<person name="Siwarski D."/>
<person name="Iyer R."/>
<person name="Magrath I."/>
</authorList>
<dbReference type="PubMed" id="8220424"/>
<dbReference type="DOI" id="10.1038/ng0993-56"/>
</citation>
<scope>INVOLVEMENT IN BURKITT LYMPHOMA</scope>
<scope>VARIANTS ASP-39; SER-57; ALA-59 AND THR-86</scope>
</reference>
<reference key="20">
<citation type="journal article" date="1993" name="Proc. Natl. Acad. Sci. U.S.A." volume="90" first="3216" last="3220">
<title>Transactivation of gene expression by Myc is inhibited by mutation at the phosphorylation sites Thr-58 and Ser-62.</title>
<authorList>
<person name="Gupta S."/>
<person name="Seth A."/>
<person name="Davis R.J."/>
</authorList>
<dbReference type="PubMed" id="8386367"/>
<dbReference type="DOI" id="10.1073/pnas.90.8.3216"/>
</citation>
<scope>PHOSPHORYLATION AT THR-58 AND SER-62</scope>
</reference>
<reference key="21">
<citation type="journal article" date="1995" name="J. Biol. Chem." volume="270" first="18961" last="18965">
<title>c-Myc is glycosylated at threonine 58, a known phosphorylation site and a mutational hot spot in lymphomas.</title>
<authorList>
<person name="Chou T.-Y."/>
<person name="Hart G.W."/>
<person name="Dang C.V."/>
</authorList>
<dbReference type="PubMed" id="7642555"/>
<dbReference type="DOI" id="10.1074/jbc.270.32.18961"/>
</citation>
<scope>GLYCOSYLATION AT THR-58</scope>
</reference>
<reference key="22">
<citation type="journal article" date="1997" name="FEBS Lett." volume="414" first="465" last="470">
<title>c-Raf kinase binds to N-terminal domain of c-Myc.</title>
<authorList>
<person name="Alexandrov I."/>
<person name="Shlyakhova L."/>
<person name="Vartanian A."/>
<person name="Zajac-Kaye M."/>
<person name="Alexandrova N."/>
</authorList>
<dbReference type="PubMed" id="9315742"/>
<dbReference type="DOI" id="10.1016/s0014-5793(97)00992-7"/>
</citation>
<scope>PHOSPHORYLATION AT THR-8</scope>
</reference>
<reference key="23">
<citation type="journal article" date="2004" name="EMBO J." volume="23" first="2116" last="2125">
<title>Phosphorylation-dependent degradation of c-Myc is mediated by the F-box protein Fbw7.</title>
<authorList>
<person name="Yada M."/>
<person name="Hatakeyama S."/>
<person name="Kamura T."/>
<person name="Nishiyama M."/>
<person name="Tsunematsu R."/>
<person name="Imaki H."/>
<person name="Ishida N."/>
<person name="Okumura F."/>
<person name="Nakayama K."/>
<person name="Nakayama K.I."/>
</authorList>
<dbReference type="PubMed" id="15103331"/>
<dbReference type="DOI" id="10.1038/sj.emboj.7600217"/>
</citation>
<scope>UBIQUITINATION</scope>
<scope>INTERACTION WITH FBXW7</scope>
<scope>PHOSPHORYLATION AT THR-58 AND SER-62</scope>
<scope>MUTAGENESIS OF THR-58 AND SER-62</scope>
</reference>
<reference key="24">
<citation type="journal article" date="2005" name="Biochem. Biophys. Res. Commun." volume="336" first="274" last="280">
<title>Six lysine residues on c-Myc are direct substrates for acetylation by p300.</title>
<authorList>
<person name="Zhang K."/>
<person name="Faiola F."/>
<person name="Martinez E."/>
</authorList>
<dbReference type="PubMed" id="16126174"/>
<dbReference type="DOI" id="10.1016/j.bbrc.2005.08.075"/>
</citation>
<scope>ACETYLATION AT LYS-143; LYS-157; LYS-275; LYS-317; LYS-323 AND LYS-371</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY</scope>
</reference>
<reference key="25">
<citation type="journal article" date="2005" name="Nat. Cell Biol." volume="7" first="311" last="318">
<title>c-Myc binds to human ribosomal DNA and stimulates transcription of rRNA genes by RNA polymerase I.</title>
<authorList>
<person name="Grandori C."/>
<person name="Gomez-Roman N."/>
<person name="Felton-Edkins Z.A."/>
<person name="Ngouenet C."/>
<person name="Galloway D.A."/>
<person name="Eisenman R.N."/>
<person name="White R.J."/>
</authorList>
<dbReference type="PubMed" id="15723054"/>
<dbReference type="DOI" id="10.1038/ncb1224"/>
</citation>
<scope>INTERACTION WITH TAF1C</scope>
</reference>
<reference key="26">
<citation type="journal article" date="2005" name="Oncogene" volume="24" first="1982" last="1993">
<title>PARP-10, a novel Myc-interacting protein with poly(ADP-ribose) polymerase activity, inhibits transformation.</title>
<authorList>
<person name="Yu M."/>
<person name="Schreek S."/>
<person name="Cerni C."/>
<person name="Schamberger C."/>
<person name="Lesniewicz K."/>
<person name="Poreba E."/>
<person name="Vervoorts J."/>
<person name="Walsemann G."/>
<person name="Groetzinger J."/>
<person name="Kremmer E."/>
<person name="Mehraein Y."/>
<person name="Mertsching J."/>
<person name="Kraft R."/>
<person name="Austen M."/>
<person name="Luescher-Firzlaff J."/>
<person name="Luescher B."/>
</authorList>
<dbReference type="PubMed" id="15674325"/>
<dbReference type="DOI" id="10.1038/sj.onc.1208410"/>
</citation>
<scope>INTERACTION WITH PARP10</scope>
</reference>
<reference key="27">
<citation type="journal article" date="2006" name="Cell" volume="127" first="635" last="648">
<title>Global, in vivo, and site-specific phosphorylation dynamics in signaling networks.</title>
<authorList>
<person name="Olsen J.V."/>
<person name="Blagoev B."/>
<person name="Gnad F."/>
<person name="Macek B."/>
<person name="Kumar C."/>
<person name="Mortensen P."/>
<person name="Mann M."/>
</authorList>
<dbReference type="PubMed" id="17081983"/>
<dbReference type="DOI" id="10.1016/j.cell.2006.09.026"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-58</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
</source>
</reference>
<reference key="28">
<citation type="journal article" date="2007" name="Cell" volume="130" first="51" last="62">
<title>CIP2A inhibits PP2A in human malignancies.</title>
<authorList>
<person name="Junttila M.R."/>
<person name="Puustinen P."/>
<person name="Niemelae M."/>
<person name="Ahola R."/>
<person name="Arnold H."/>
<person name="Boettzauw T."/>
<person name="Ala-Aho R."/>
<person name="Nielsen C."/>
<person name="Ivaska J."/>
<person name="Taya Y."/>
<person name="Lu S.-L."/>
<person name="Lin S."/>
<person name="Chan E.K.L."/>
<person name="Wang X.-J."/>
<person name="Grenman R."/>
<person name="Kast J."/>
<person name="Kallunki T."/>
<person name="Sears R."/>
<person name="Kaehaeri V.-M."/>
<person name="Westermarck J."/>
</authorList>
<dbReference type="PubMed" id="17632056"/>
<dbReference type="DOI" id="10.1016/j.cell.2007.04.044"/>
</citation>
<scope>INTERACTION WITH CIP2A</scope>
</reference>
<reference key="29">
<citation type="journal article" date="2007" name="Cell" volume="131" first="861" last="872">
<title>Induction of pluripotent stem cells from adult human fibroblasts by defined factors.</title>
<authorList>
<person name="Takahashi K."/>
<person name="Tanabe K."/>
<person name="Ohnuki M."/>
<person name="Narita M."/>
<person name="Ichisaka T."/>
<person name="Tomoda K."/>
<person name="Yamanaka S."/>
</authorList>
<dbReference type="PubMed" id="18035408"/>
<dbReference type="DOI" id="10.1016/j.cell.2007.11.019"/>
</citation>
<scope>BIOTECHNOLOGY</scope>
</reference>
<reference key="30">
<citation type="journal article" date="2007" name="Cell Cycle" volume="6" first="2327" last="2331">
<title>Fbw7 and Usp28 regulate myc protein stability in response to DNA damage.</title>
<authorList>
<person name="Popov N."/>
<person name="Herold S."/>
<person name="Llamazares M."/>
<person name="Schulein C."/>
<person name="Eilers M."/>
</authorList>
<dbReference type="PubMed" id="17873522"/>
<dbReference type="DOI" id="10.4161/cc.6.19.4804"/>
</citation>
<scope>UBIQUITINATION</scope>
<scope>DEUBIQUITINATION BY USP28</scope>
<scope>INTERACTION WITH FBXW7</scope>
</reference>
<reference key="31">
<citation type="journal article" date="2007" name="Genes Dev." volume="21" first="537" last="551">
<title>The Trithorax group protein Lid is a trimethyl histone H3K4 demethylase required for dMyc-induced cell growth.</title>
<authorList>
<person name="Secombe J."/>
<person name="Li L."/>
<person name="Carlos L."/>
<person name="Eisenman R.N."/>
</authorList>
<dbReference type="PubMed" id="17311883"/>
<dbReference type="DOI" id="10.1101/gad.1523007"/>
</citation>
<scope>INTERACTION WITH KDM5A AND KDM5B</scope>
</reference>
<reference key="32">
<citation type="journal article" date="2007" name="Mol. Cancer Ther." volume="6" first="542" last="551">
<title>Identification of Myc-associated protein with JmjC domain as a novel therapeutic target oncogene for lung cancer.</title>
<authorList>
<person name="Suzuki C."/>
<person name="Takahashi K."/>
<person name="Hayama S."/>
<person name="Ishikawa N."/>
<person name="Kato T."/>
<person name="Ito T."/>
<person name="Tsuchiya E."/>
<person name="Nakamura Y."/>
<person name="Daigo Y."/>
</authorList>
<dbReference type="PubMed" id="17308053"/>
<dbReference type="DOI" id="10.1158/1535-7163.mct-06-0659"/>
</citation>
<scope>INTERACTION WITH RIOX1</scope>
</reference>
<reference key="33">
<citation type="journal article" date="2007" name="Nat. Cell Biol." volume="9" first="765" last="774">
<title>The ubiquitin-specific protease USP28 is required for MYC stability.</title>
<authorList>
<person name="Popov N."/>
<person name="Wanzel M."/>
<person name="Madiredjo M."/>
<person name="Zhang D."/>
<person name="Beijersbergen R."/>
<person name="Bernards R."/>
<person name="Moll R."/>
<person name="Elledge S.J."/>
<person name="Eilers M."/>
</authorList>
<dbReference type="PubMed" id="17558397"/>
<dbReference type="DOI" id="10.1038/ncb1601"/>
</citation>
<scope>UBIQUITINATION</scope>
<scope>DEUBIQUITINATION BY USP28</scope>
<scope>INTERACTION WITH FBXW7</scope>
<scope>SUBCELLULAR LOCATION</scope>
<scope>PHOSPHORYLATION AT THR-58 AND SER-62</scope>
<scope>MUTAGENESIS OF THR-58 AND SER-62</scope>
</reference>
<reference key="34">
<citation type="journal article" date="2008" name="Proc. Natl. Acad. Sci. U.S.A." volume="105" first="10762" last="10767">
<title>A quantitative atlas of mitotic phosphorylation.</title>
<authorList>
<person name="Dephoure N."/>
<person name="Zhou C."/>
<person name="Villen J."/>
<person name="Beausoleil S.A."/>
<person name="Bakalarski C.E."/>
<person name="Elledge S.J."/>
<person name="Gygi S.P."/>
</authorList>
<dbReference type="PubMed" id="18669648"/>
<dbReference type="DOI" id="10.1073/pnas.0805139105"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-58; SER-62 AND SER-71</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
</source>
</reference>
<reference key="35">
<citation type="journal article" date="2009" name="Anal. Chem." volume="81" first="4493" last="4501">
<title>Lys-N and trypsin cover complementary parts of the phosphoproteome in a refined SCX-based approach.</title>
<authorList>
<person name="Gauci S."/>
<person name="Helbig A.O."/>
<person name="Slijper M."/>
<person name="Krijgsveld J."/>
<person name="Heck A.J."/>
<person name="Mohammed S."/>
</authorList>
<dbReference type="PubMed" id="19413330"/>
<dbReference type="DOI" id="10.1021/ac9004309"/>
</citation>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="36">
<citation type="journal article" date="2009" name="Science" volume="325" first="834" last="840">
<title>Lysine acetylation targets protein complexes and co-regulates major cellular functions.</title>
<authorList>
<person name="Choudhary C."/>
<person name="Kumar C."/>
<person name="Gnad F."/>
<person name="Nielsen M.L."/>
<person name="Rehman M."/>
<person name="Walther T.C."/>
<person name="Olsen J.V."/>
<person name="Mann M."/>
</authorList>
<dbReference type="PubMed" id="19608861"/>
<dbReference type="DOI" id="10.1126/science.1175371"/>
</citation>
<scope>ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-148</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="37">
<citation type="journal article" date="2010" name="Cancer Res." volume="70" first="6687" last="6691">
<title>Tipping the balance: Cdk2 enables Myc to suppress senescence.</title>
<authorList>
<person name="Hydbring P."/>
<person name="Larsson L.-G."/>
</authorList>
<dbReference type="PubMed" id="20713526"/>
<dbReference type="DOI" id="10.1158/0008-5472.can-10-1383"/>
</citation>
<scope>REVIEW ON SENESCENCE</scope>
<scope>PHOSPHORYLATION AT SER-62 BY CDK2</scope>
<scope>MUTAGENESIS OF THR-58 AND SER-62</scope>
</reference>
<reference key="38">
<citation type="journal article" date="2010" name="Proc. Natl. Acad. Sci. U.S.A." volume="107" first="58" last="63">
<title>Phosphorylation by Cdk2 is required for Myc to repress Ras-induced senescence in cotransformation.</title>
<authorList>
<person name="Hydbring P."/>
<person name="Bahram F."/>
<person name="Su Y."/>
<person name="Tronnersjoe S."/>
<person name="Hoegstrand K."/>
<person name="von der Lehr N."/>
<person name="Sharifi H.R."/>
<person name="Lilischkis R."/>
<person name="Hein N."/>
<person name="Wu S."/>
<person name="Vervoorts J."/>
<person name="Henriksson M."/>
<person name="Grandien A."/>
<person name="Luescher B."/>
<person name="Larsson L.-G."/>
</authorList>
<dbReference type="PubMed" id="19966300"/>
<dbReference type="DOI" id="10.1073/pnas.0900121106"/>
</citation>
<scope>PHOSPHORYLATION AT SER-62 BY CDK2</scope>
<scope>MUTAGENESIS OF THR-58 AND SER-62</scope>
</reference>
<reference key="39">
<citation type="journal article" date="2010" name="Genes Dev." volume="24" first="1236" last="1241">
<title>Myc protein is stabilized by suppression of a novel E3 ligase complex in cancer cells.</title>
<authorList>
<person name="Choi S.H."/>
<person name="Wright J.B."/>
<person name="Gerber S.A."/>
<person name="Cole M.D."/>
</authorList>
<dbReference type="PubMed" id="20551172"/>
<dbReference type="DOI" id="10.1101/gad.1920310"/>
</citation>
<scope>UBIQUITINATION</scope>
</reference>
<reference key="40">
<citation type="journal article" date="2010" name="Sci. Signal." volume="3" first="RA3" last="RA3">
<title>Quantitative phosphoproteomics reveals widespread full phosphorylation site occupancy during mitosis.</title>
<authorList>
<person name="Olsen J.V."/>
<person name="Vermeulen M."/>
<person name="Santamaria A."/>
<person name="Kumar C."/>
<person name="Miller M.L."/>
<person name="Jensen L.J."/>
<person name="Gnad F."/>
<person name="Cox J."/>
<person name="Jensen T.S."/>
<person name="Nigg E.A."/>
<person name="Brunak S."/>
<person name="Mann M."/>
</authorList>
<dbReference type="PubMed" id="20068231"/>
<dbReference type="DOI" id="10.1126/scisignal.2000475"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-6 AND SER-161</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
</source>
</reference>
<reference key="41">
<citation type="journal article" date="2011" name="Sci. Signal." volume="4" first="RS3" last="RS3">
<title>System-wide temporal characterization of the proteome and phosphoproteome of human embryonic stem cell differentiation.</title>
<authorList>
<person name="Rigbolt K.T."/>
<person name="Prokhorova T.A."/>
<person name="Akimov V."/>
<person name="Henningsen J."/>
<person name="Johansen P.T."/>
<person name="Kratchmarova I."/>
<person name="Kassem M."/>
<person name="Mann M."/>
<person name="Olsen J.V."/>
<person name="Blagoev B."/>
</authorList>
<dbReference type="PubMed" id="21406692"/>
<dbReference type="DOI" id="10.1126/scisignal.2001570"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-58 AND SER-62</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="42">
<citation type="journal article" date="2012" name="J. Clin. Invest." volume="122" first="859" last="872">
<title>DYRK2 priming phosphorylation of c-Jun and c-Myc modulates cell cycle progression in human cancer cells.</title>
<authorList>
<person name="Taira N."/>
<person name="Mimoto R."/>
<person name="Kurata M."/>
<person name="Yamaguchi T."/>
<person name="Kitagawa M."/>
<person name="Miki Y."/>
<person name="Yoshida K."/>
</authorList>
<dbReference type="PubMed" id="22307329"/>
<dbReference type="DOI" id="10.1172/jci60818"/>
</citation>
<scope>PHOSPHORYLATION AT SER-62</scope>
<scope>MUTAGENESIS OF SER-62</scope>
</reference>
<reference key="43">
<citation type="journal article" date="2013" name="J. Proteome Res." volume="12" first="260" last="271">
<title>Toward a comprehensive characterization of a human cancer cell phosphoproteome.</title>
<authorList>
<person name="Zhou H."/>
<person name="Di Palma S."/>
<person name="Preisinger C."/>
<person name="Peng M."/>
<person name="Polat A.N."/>
<person name="Heck A.J."/>
<person name="Mohammed S."/>
</authorList>
<dbReference type="PubMed" id="23186163"/>
<dbReference type="DOI" id="10.1021/pr300630k"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-6; THR-58; SER-62; SER-71 AND SER-293</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
<tissue>Erythroleukemia</tissue>
</source>
</reference>
<reference key="44">
<citation type="journal article" date="2014" name="Elife" volume="3" first="E02349" last="E02349">
<title>tRNA synthetase counteracts c-Myc to develop functional vasculature.</title>
<authorList>
<person name="Shi Y."/>
<person name="Xu X."/>
<person name="Zhang Q."/>
<person name="Fu G."/>
<person name="Mo Z."/>
<person name="Wang G.S."/>
<person name="Kishi S."/>
<person name="Yang X.L."/>
</authorList>
<dbReference type="PubMed" id="24940000"/>
<dbReference type="DOI" id="10.7554/elife.02349"/>
</citation>
<scope>FUNCTION</scope>
</reference>
<reference key="45">
<citation type="journal article" date="2015" name="Am. J. Pathol." volume="185" first="2061" last="2068">
<title>The nucleolar protein GLTSCR2 is an upstream negative regulator of the oncogenic Nucleophosmin-MYC axis.</title>
<authorList>
<person name="Kim J.Y."/>
<person name="Cho Y.E."/>
<person name="Park J.H."/>
</authorList>
<dbReference type="PubMed" id="25956029"/>
<dbReference type="DOI" id="10.1016/j.ajpath.2015.03.016"/>
</citation>
<scope>FUNCTION</scope>
<scope>INTERACTION WITH NPM1</scope>
</reference>
<reference key="46">
<citation type="journal article" date="2015" name="Proc. Natl. Acad. Sci. U.S.A." volume="112" first="3734" last="3739">
<title>The nucleolar ubiquitin-specific protease USP36 deubiquitinates and stabilizes c-Myc.</title>
<authorList>
<person name="Sun X.X."/>
<person name="He X."/>
<person name="Yin L."/>
<person name="Komada M."/>
<person name="Sears R.C."/>
<person name="Dai M.S."/>
</authorList>
<dbReference type="PubMed" id="25775507"/>
<dbReference type="DOI" id="10.1073/pnas.1411713112"/>
</citation>
<scope>UBIQUITINATION</scope>
<scope>DEUBIQUITINATION BY USP36</scope>
<scope>INTERACTION WITH FBXW7</scope>
<scope>SUBCELLULAR LOCATION</scope>
</reference>
<reference key="47">
<citation type="journal article" date="2017" name="Nat. Struct. Mol. Biol." volume="24" first="325" last="336">
<title>Site-specific mapping of the human SUMO proteome reveals co-modification with phosphorylation.</title>
<authorList>
<person name="Hendriks I.A."/>
<person name="Lyon D."/>
<person name="Young C."/>
<person name="Jensen L.J."/>
<person name="Vertegaal A.C."/>
<person name="Nielsen M.L."/>
</authorList>
<dbReference type="PubMed" id="28112733"/>
<dbReference type="DOI" id="10.1038/nsmb.3366"/>
</citation>
<scope>SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-52; LYS-143; LYS-148 AND LYS-298</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="48">
<citation type="journal article" date="1998" name="J. Mol. Biol." volume="281" first="165" last="181">
<title>Insights into the mechanism of heterodimerization from the 1H-NMR solution structure of the c-Myc-Max heterodimeric leucine zipper.</title>
<authorList>
<person name="Lavigne P."/>
<person name="Crump M.P."/>
<person name="Gagne S.M."/>
<person name="Hodges R.S."/>
<person name="Kay C.M."/>
<person name="Sykes B.D."/>
</authorList>
<dbReference type="PubMed" id="9680483"/>
<dbReference type="DOI" id="10.1006/jmbi.1998.1914"/>
</citation>
<scope>STRUCTURE BY NMR OF 402-434 IN COMPLEX WITH MAX</scope>
</reference>
<reference key="49">
<citation type="journal article" date="1991" name="Genes Chromosomes Cancer" volume="3" first="24" last="36">
<title>A chromosome 12 coding region is juxtaposed to the MYC protooncogene locus in a t(8;12)(q24;q22) translocation in a case of B-cell chronic lymphocytic leukemia.</title>
<authorList>
<person name="Rimokh R."/>
<person name="Rouault J.P."/>
<person name="Wahbi K."/>
<person name="Gadoux M."/>
<person name="Lafage M."/>
<person name="Archimbaud E."/>
<person name="Charrin C."/>
<person name="Gentilhomme O."/>
<person name="Germain D."/>
<person name="Samarut J."/>
</authorList>
<dbReference type="PubMed" id="2069907"/>
<dbReference type="DOI" id="10.1002/gcc.2870030106"/>
</citation>
<scope>CHROMOSOMAL TRANSLOCATION WITH BTG1</scope>
</reference>
<comment type="function">
<text evidence="11 28 30">Transcription factor that binds DNA in a non-specific manner, yet also specifically recognizes the core sequence 5'-CAC[GA]TG-3'. Activates the transcription of growth-related genes. Binds to the VEGFA promoter, promoting VEGFA production and subsequent sprouting angiogenesis (PubMed:24940000). Regulator of somatic reprogramming, controls self-renewal of embryonic stem cells. Functions with TAF6L to activate target gene expression through RNA polymerase II pause release (By similarity).</text>
</comment>
<comment type="subunit">
<text evidence="11 13 14 15 17 18 19 20 21 29 30 36">Efficient DNA binding requires dimerization with another bHLH protein. Binds DNA as a heterodimer with MAX (PubMed:9680483). Interacts with TAF1C and SPAG9. Interacts with PARP10. Interacts with KDM5A and KDM5B. Interacts (when phosphorylated at Thr-58 and Ser-62) with FBXW7(PubMed:25775507, PubMed:17558397). Interacts with PIM2. Interacts with RIOX1. The heterodimer MYC:MAX interacts with ABI1; the interaction may enhance MYC:MAX transcriptional activity. Interacts with TRIM6 (By similarity). Interacts with NPM1; the binary complex is recruited to the promoter of MYC target genes and enhances their transcription (PubMed:25956029). Interacts with CIP2A; leading to the stabilization of MYC (PubMed:17632056).</text>
</comment>
<comment type="interaction">
<interactant intactId="EBI-447544">
<id>P01106</id>
</interactant>
<interactant intactId="EBI-710484">
<id>O15169</id>
<label>AXIN1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>10</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-447544">
<id>P01106</id>
</interactant>
<interactant intactId="EBI-7689134">
<id>O00499-10</id>
<label>BIN1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-447544">
<id>P01106</id>
</interactant>
<interactant intactId="EBI-7689211">
<id>O00499-11</id>
<label>BIN1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-447544">
<id>P01106</id>
</interactant>
<interactant intactId="EBI-1383460">
<id>Q15059</id>
<label>BRD3</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-447544">
<id>P01106</id>
</interactant>
<interactant intactId="EBI-355410">
<id>Q8N163</id>
<label>CCAR2</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>8</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-447544">
<id>P01106</id>
</interactant>
<interactant intactId="EBI-295644">
<id>P11802</id>
<label>CDK4</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-447544">
<id>P01106</id>
</interactant>
<interactant intactId="EBI-308614">
<id>Q86XR8</id>
<label>CEP57</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-447544">
<id>P01106</id>
</interactant>
<interactant intactId="EBI-372916">
<id>Q14839</id>
<label>CHD4</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-447544">
<id>P01106</id>
</interactant>
<interactant intactId="EBI-81249">
<id>O15111</id>
<label>CHUK</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-447544">
<id>P01106</id>
</interactant>
<interactant intactId="EBI-1379376">
<id>Q8TCG1</id>
<label>CIP2A</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-447544">
<id>P01106</id>
</interactant>
<interactant intactId="EBI-357897">
<id>Q15029</id>
<label>EFTUD2</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>5</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-447544">
<id>P01106</id>
</interactant>
<interactant intactId="EBI-399163">
<id>Q96L91</id>
<label>EP400</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>4</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-447544">
<id>P01106</id>
</interactant>
<interactant intactId="EBI-15698003">
<id>Q96L91-2</id>
<label>EP400</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-447544">
<id>P01106</id>
</interactant>
<interactant intactId="EBI-359574">
<id>Q969H0</id>
<label>FBXW7</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>6</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-447544">
<id>P01106</id>
</interactant>
<interactant intactId="EBI-914770">
<id>Q8N3Y1</id>
<label>FBXW8</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-447544">
<id>P01106</id>
</interactant>
<interactant intactId="EBI-1644164">
<id>O43524</id>
<label>FOXO3</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-447544">
<id>P01106</id>
</interactant>
<interactant intactId="EBI-15870655">
<id>P49841-2</id>
<label>GSK3B</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-447544">
<id>P01106</id>
</interactant>
<interactant intactId="EBI-301821">
<id>Q92769</id>
<label>HDAC2</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-447544">
<id>P01106</id>
</interactant>
<interactant intactId="EBI-607682">
<id>O15379</id>
<label>HDAC3</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>6</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-447544">
<id>P01106</id>
</interactant>
<interactant intactId="EBI-81279">
<id>Q9Y6K9</id>
<label>IKBKG</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-447544">
<id>P01106</id>
</interactant>
<interactant intactId="EBI-710124">
<id>O60341</id>
<label>KDM1A</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>4</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-447544">
<id>P01106</id>
</interactant>
<interactant intactId="EBI-751711">
<id>P61244</id>
<label>MAX</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>36</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-447544">
<id>P01106</id>
</interactant>
<interactant intactId="EBI-1783068">
<id>O95983</id>
<label>MBD3</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-447544">
<id>P01106</id>
</interactant>
<interactant intactId="EBI-355924">
<id>P33993</id>
<label>MCM7</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>6</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-447544">
<id>P01106</id>
</interactant>
<interactant intactId="EBI-373498">
<id>A9UHW6</id>
<label>MIF4GD</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-447544">
<id>P01106</id>
</interactant>
<interactant intactId="EBI-348555">
<id>O75928</id>
<label>PIAS2</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>4</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-447544">
<id>P01106</id>
</interactant>
<interactant intactId="EBI-714158">
<id>Q13526</id>
<label>PIN1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>5</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-447544">
<id>P01106</id>
</interactant>
<interactant intactId="EBI-354380">
<id>P62913</id>
<label>RPL11</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-447544">
<id>P01106</id>
</interactant>
<interactant intactId="EBI-540462">
<id>O75182</id>
<label>SIN3B</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>7</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-447544">
<id>P01106</id>
</interactant>
<interactant intactId="EBI-1802965">
<id>Q96EB6</id>
<label>SIRT1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>4</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-447544">
<id>P01106</id>
</interactant>
<interactant intactId="EBI-712415">
<id>Q8N6T7</id>
<label>SIRT6</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-447544">
<id>P01106</id>
</interactant>
<interactant intactId="EBI-456291">
<id>Q13309</id>
<label>SKP2</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-447544">
<id>P01106</id>
</interactant>
<interactant intactId="EBI-749336">
<id>Q8TAD8</id>
<label>SNIP1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>9</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-447544">
<id>P01106</id>
</interactant>
<interactant intactId="EBI-298336">
<id>P08047</id>
<label>SP1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>4</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-447544">
<id>P01106</id>
</interactant>
<interactant intactId="EBI-876302">
<id>P11387</id>
<label>TOP1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-447544">
<id>P01106</id>
</interactant>
<interactant intactId="EBI-396540">
<id>Q12888</id>
<label>TP53BP1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-447544">
<id>P01106</id>
</interactant>
<interactant intactId="EBI-308443">
<id>Q14669</id>
<label>TRIP12</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>7</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-447544">
<id>P01106</id>
</interactant>
<interactant intactId="EBI-399128">
<id>Q9Y4A5</id>
<label>TRRAP</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>4</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-447544">
<id>P01106</id>
</interactant>
<interactant intactId="EBI-3390054">
<id>P0CG48</id>
<label>UBC</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>5</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-447544">
<id>P01106</id>
</interactant>
<interactant intactId="EBI-396235">
<id>P17480</id>
<label>UBTF</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-447544">
<id>P01106</id>
</interactant>
<interactant intactId="EBI-372156">
<id>Q13105</id>
<label>ZBTB17</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>9</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-447544">
<id>P01106</id>
</interactant>
<interactant intactId="EBI-866453">
<id>P03129</id>
<label>E7</label>
</interactant>
<organismsDiffer>true</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-447544">
<id>P01106</id>
</interactant>
<interactant intactId="EBI-7005254">
<id>P04020</id>
<label>E7</label>
</interactant>
<organismsDiffer>true</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-447544">
<id>P01106</id>
</interactant>
<interactant intactId="EBI-1776887">
<id>P06788</id>
<label>E7</label>
</interactant>
<organismsDiffer>true</organismsDiffer>
<experiments>5</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-447544">
<id>P01106</id>
</interactant>
<interactant intactId="EBI-9255985">
<id>P03204</id>
<label>EBNA6</label>
</interactant>
<organismsDiffer>true</organismsDiffer>
<experiments>11</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-447544">
<id>P01106</id>
</interactant>
<interactant intactId="EBI-1184963">
<id>P52164</id>
<label>Max</label>
</interactant>
<organismsDiffer>true</organismsDiffer>
<experiments>4</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-447544">
<id>P01106</id>
</interactant>
<interactant intactId="EBI-591450">
<id>Q62141</id>
<label>Sin3b</label>
</interactant>
<organismsDiffer>true</organismsDiffer>
<experiments>8</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-447544">
<id>P01106</id>
</interactant>
<interactant intactId="EBI-617698">
<id>P03070</id>
</interactant>
<organismsDiffer>true</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="subcellular location">
<subcellularLocation>
<location evidence="19">Nucleus</location>
<location evidence="19">Nucleoplasm</location>
</subcellularLocation>
<subcellularLocation>
<location evidence="19 29">Nucleus</location>
<location evidence="19 29">Nucleolus</location>
</subcellularLocation>
</comment>
<comment type="alternative products">
<event type="alternative splicing"/>
<isoform>
<id>P01106-1</id>
<name>1</name>
<sequence type="displayed"/>
</isoform>
<isoform>
<id>P01106-2</id>
<name>2</name>
<sequence type="described" ref="VSP_037813"/>
</isoform>
</comment>
<comment type="PTM">
<text evidence="10 13 19 23 25 27 34">Phosphorylated by PRKDC. Phosphorylation at Ser-329 by PIM2 leads to the stabilization of MYC (By similarity). Phosphorylation at Ser-62 by CDK2 prevents Ras-induced senescence. Phosphorylated at Ser-62 by DYRK2; this primes the protein for subsequent phosphorylation by GSK3B at Thr-58. Phosphorylation at Thr-58 and Ser-62 by GSK3 is required for ubiquitination and degradation by the proteasome.</text>
</comment>
<comment type="PTM">
<text evidence="11 13 19 23 25 27 29 34">Ubiquitinated by the SCF(FBXW7) complex when phosphorylated at Thr-58 and Ser-62, leading to its degradation by the proteasome. In the nucleoplasm, ubiquitination is counteracted by USP28, which interacts with isoform 1 of FBXW7 (FBW7alpha), leading to its deubiquitination and preventing degradation. In the nucleolus, however, ubiquitination is not counteracted by USP28 but by USP36, due to the lack of interaction between isoform 3 of FBXW7 (FBW7gamma) and USP28, explaining the selective MYC degradation in the nucleolus (PubMed:25775507,PubMed:17558397). Also polyubiquitinated by the DCX(TRUSS) complex. Ubiquitinated by TRIM6 in a phosphorylation-independent manner (By similarity).</text>
</comment>
<comment type="disease">
<text evidence="24">A chromosomal aberration involving MYC may be a cause of a form of B-cell chronic lymphocytic leukemia. Translocation t(8;12)(q24;q22) with BTG1.</text>
</comment>
<comment type="disease" evidence="26 33">
<disease id="DI-02613">
<name>Burkitt lymphoma</name>
<acronym>BL</acronym>
<description>A form of undifferentiated malignant lymphoma commonly manifested as a large osteolytic lesion in the jaw or as an abdominal mass.</description>
<dbReference type="MIM" id="113970"/>
</disease>
<text>The gene represented in this entry is involved in disease pathogenesis. Chromosomal aberrations involving MYC are usually found in Burkitt lymphoma. Translocations t(8;14), t(8;22) or t(2;8) which juxtapose MYC to one of the heavy or light chain immunoglobulin gene loci.</text>
</comment>
<comment type="biotechnology">
<text evidence="22">POU5F1/OCT4, SOX2, MYC/c-Myc and KLF4 are the four Yamanaka factors. When combined, these factors are sufficient to reprogram differentiated cells to an embryonic-like state designated iPS (induced pluripotent stem) cells. iPS cells exhibit the morphology and growth properties of ES cells and express ES cell marker genes.</text>
</comment>
<comment type="miscellaneous">
<molecule>Isoform 2</molecule>
<text evidence="39">Initiates from CTG codon.</text>
</comment>
<comment type="online information" name="Atlas of Genetics and Cytogenetics in Oncology and Haematology">
<link uri="http://atlasgeneticsoncology.org/Genes/MYCID27.html"/>
</comment>
<comment type="online information" name="NIEHS-SNPs">
<link uri="http://egp.gs.washington.edu/data/myc/"/>
</comment>
<comment type="online information" name="Wikipedia">
<link uri="https://en.wikipedia.org/wiki/Myc"/>
<text>Myc entry</text>
</comment>
<dbReference type="EMBL" id="L00058">
<property type="protein sequence ID" value="AAA59882.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="L00057">
<property type="protein sequence ID" value="AAA59882.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="K00535">
<property type="protein sequence ID" value="AAA59880.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="K00534">
<property type="protein sequence ID" value="AAA59880.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="K00535">
<property type="protein sequence ID" value="ABW69847.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="K00534">
<property type="protein sequence ID" value="ABW69847.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="X00196">
<property type="protein sequence ID" value="CAA25015.2"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="X00198">
<property type="protein sequence ID" value="CAA25015.2"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="X00364">
<property type="protein sequence ID" value="CAA25106.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="V00568">
<property type="protein sequence ID" value="CAA23831.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="K01906">
<property type="protein sequence ID" value="AAA59881.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="K01905">
<property type="protein sequence ID" value="AAA59881.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="K02276">
<property type="protein sequence ID" value="AAA36340.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="X00676">
<property type="protein sequence ID" value="CAA25288.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="D10493">
<property type="protein sequence ID" value="BAA01374.2"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="D10493">
<property type="protein sequence ID" value="BAA01375.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="BT019768">
<property type="protein sequence ID" value="AAV38573.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AY214166">
<property type="protein sequence ID" value="AAO21131.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AK312883">
<property type="protein sequence ID" value="BAG35731.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AC103819">
<property type="status" value="NOT_ANNOTATED_CDS"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="CH471060">
<property type="protein sequence ID" value="EAW92098.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="BC000141">
<property type="protein sequence ID" value="AAH00141.2"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="BC000917">
<property type="protein sequence ID" value="AAH00917.2"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="BC058901">
<property type="protein sequence ID" value="AAH58901.2"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="M13929">
<property type="protein sequence ID" value="AAA88092.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="CCDS" id="CCDS6359.2">
<molecule id="P01106-2"/>
</dbReference>
<dbReference type="PIR" id="A01349">
<property type="entry name" value="TVHUM"/>
</dbReference>
<dbReference type="PIR" id="A01350">
<property type="entry name" value="TVHUT"/>
</dbReference>
<dbReference type="RefSeq" id="NP_002458.2">
<molecule id="P01106-2"/>
<property type="nucleotide sequence ID" value="NM_002467.4"/>
</dbReference>
<dbReference type="PDB" id="1A93">
<property type="method" value="NMR"/>
<property type="chains" value="A=406-434"/>
</dbReference>
<dbReference type="PDB" id="1EE4">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.10"/>
<property type="chains" value="C/D/E/F=320-328"/>
</dbReference>
<dbReference type="PDB" id="1MV0">
<property type="method" value="NMR"/>
<property type="chains" value="A=55-68"/>
</dbReference>
<dbReference type="PDB" id="1NKP">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.80"/>
<property type="chains" value="A/D=353-434"/>
</dbReference>
<dbReference type="PDB" id="2A93">
<property type="method" value="NMR"/>
<property type="chains" value="A=406-434"/>
</dbReference>
<dbReference type="PDB" id="2OR9">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.70"/>
<property type="chains" value="P=410-419"/>
</dbReference>
<dbReference type="PDB" id="4Y7R">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.90"/>
<property type="chains" value="B=260-267"/>
</dbReference>
<dbReference type="PDB" id="5I4Z">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.95"/>
<property type="chains" value="A/B=350-439"/>
</dbReference>
<dbReference type="PDB" id="5I50">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.70"/>
<property type="chains" value="A/B=350-439"/>
</dbReference>
<dbReference type="PDB" id="6C4U">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.60"/>
<property type="chains" value="G/H/I/J/K/L=54-62"/>
</dbReference>
<dbReference type="PDB" id="6E16">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.40"/>
<property type="chains" value="A=96-125"/>
</dbReference>
<dbReference type="PDB" id="6E24">
<property type="method" value="X-ray"/>
<property type="resolution" value="3.00"/>
<property type="chains" value="A=96-125"/>
</dbReference>
<dbReference type="PDB" id="6G6J">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.25"/>
<property type="chains" value="A/C=351-437"/>
</dbReference>
<dbReference type="PDB" id="6G6K">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.35"/>
<property type="chains" value="A/C=351-437"/>
</dbReference>
<dbReference type="PDB" id="6G6L">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.20"/>
<property type="chains" value="A/C/E/G=351-437"/>
</dbReference>
<dbReference type="PDBsum" id="1A93"/>
<dbReference type="PDBsum" id="1EE4"/>
<dbReference type="PDBsum" id="1MV0"/>
<dbReference type="PDBsum" id="1NKP"/>
<dbReference type="PDBsum" id="2A93"/>
<dbReference type="PDBsum" id="2OR9"/>
<dbReference type="PDBsum" id="4Y7R"/>
<dbReference type="PDBsum" id="5I4Z"/>
<dbReference type="PDBsum" id="5I50"/>
<dbReference type="PDBsum" id="6C4U"/>
<dbReference type="PDBsum" id="6E16"/>
<dbReference type="PDBsum" id="6E24"/>
<dbReference type="PDBsum" id="6G6J"/>
<dbReference type="PDBsum" id="6G6K"/>
<dbReference type="PDBsum" id="6G6L"/>
<dbReference type="BMRB" id="P01106"/>
<dbReference type="SMR" id="P01106"/>
<dbReference type="BioGRID" id="110694">
<property type="interactions" value="1959"/>
</dbReference>
<dbReference type="ComplexPortal" id="CPX-1123">
<property type="entry name" value="FOXO3-MYC complex"/>
</dbReference>
<dbReference type="ComplexPortal" id="CPX-514">
<property type="entry name" value="c-MYC-BIN1 complex"/>
</dbReference>
<dbReference type="ComplexPortal" id="CPX-91">
<property type="entry name" value="Transcriptional activator Myc-Max complex"/>
</dbReference>
<dbReference type="CORUM" id="P01106"/>
<dbReference type="DIP" id="DIP-28143N"/>
<dbReference type="IntAct" id="P01106">
<property type="interactions" value="721"/>
</dbReference>
<dbReference type="MINT" id="P01106"/>
<dbReference type="STRING" id="9606.ENSP00000479618"/>
<dbReference type="BindingDB" id="P01106"/>
<dbReference type="ChEMBL" id="CHEMBL1250348"/>
<dbReference type="DrugBank" id="DB00945">
<property type="generic name" value="Acetylsalicylic acid"/>
</dbReference>
<dbReference type="DrugBank" id="DB08813">
<property type="generic name" value="Nadroparin"/>
</dbReference>
<dbReference type="GlyConnect" id="426">
<property type="glycosylation" value="1 O-Linked glycan (1 site)"/>
</dbReference>
<dbReference type="GlyGen" id="P01106">
<property type="glycosylation" value="1 site"/>
</dbReference>
<dbReference type="iPTMnet" id="P01106"/>
<dbReference type="PhosphoSitePlus" id="P01106"/>
<dbReference type="UniCarbKB" id="P01106"/>
<dbReference type="BioMuta" id="MYC"/>
<dbReference type="DMDM" id="127619"/>
<dbReference type="SWISS-2DPAGE" id="P01106"/>
<dbReference type="EPD" id="P01106"/>
<dbReference type="jPOST" id="P01106"/>
<dbReference type="MassIVE" id="P01106"/>
<dbReference type="MaxQB" id="P01106"/>
<dbReference type="PaxDb" id="P01106"/>
<dbReference type="PeptideAtlas" id="P01106"/>
<dbReference type="PRIDE" id="P01106"/>
<dbReference type="ProteomicsDB" id="51318">
<molecule id="P01106-1"/>
</dbReference>
<dbReference type="ProteomicsDB" id="51319">
<molecule id="P01106-2"/>
</dbReference>
<dbReference type="ABCD" id="P01106">
<property type="antibodies" value="6 sequenced antibodies"/>
</dbReference>
<dbReference type="Antibodypedia" id="3520">
<property type="antibodies" value="4058 antibodies"/>
</dbReference>
<dbReference type="DNASU" id="4609"/>
<dbReference type="Ensembl" id="ENST00000377970">
<molecule id="P01106-1"/>
<property type="protein sequence ID" value="ENSP00000367207"/>
<property type="gene ID" value="ENSG00000136997"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000652288">
<molecule id="P01106-1"/>
<property type="protein sequence ID" value="ENSP00000499105"/>
<property type="gene ID" value="ENSG00000136997"/>
</dbReference>
<dbReference type="GeneID" id="4609"/>
<dbReference type="KEGG" id="hsa:4609"/>
<dbReference type="UCSC" id="uc064qdj.1">
<molecule id="P01106-1"/>
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="CTD" id="4609"/>
<dbReference type="DisGeNET" id="4609"/>
<dbReference type="EuPathDB" id="HostDB:ENSG00000136997.15"/>
<dbReference type="GeneCards" id="MYC"/>
<dbReference type="HGNC" id="HGNC:7553">
<property type="gene designation" value="MYC"/>
</dbReference>
<dbReference type="HPA" id="ENSG00000136997">
<property type="expression patterns" value="Low tissue specificity"/>
</dbReference>
<dbReference type="MalaCards" id="MYC"/>
<dbReference type="MIM" id="113970">
<property type="type" value="phenotype"/>
</dbReference>
<dbReference type="MIM" id="190080">
<property type="type" value="gene"/>
</dbReference>
<dbReference type="neXtProt" id="NX_P01106"/>
<dbReference type="OpenTargets" id="ENSG00000136997"/>
<dbReference type="Orphanet" id="543">
<property type="disease" value="Burkitt lymphoma"/>
</dbReference>
<dbReference type="Orphanet" id="480541">
<property type="disease" value="High grade B-cell lymphoma with MYC and/ or BCL2 and/or BCL6 rearrangement"/>
</dbReference>
<dbReference type="Orphanet" id="99861">
<property type="disease" value="Precursor T-cell acute lymphoblastic leukemia"/>
</dbReference>
<dbReference type="PharmGKB" id="PA31353"/>
<dbReference type="eggNOG" id="KOG2483">
<property type="taxonomic scope" value="Eukaryota"/>
</dbReference>
<dbReference type="GeneTree" id="ENSGT00940000155285"/>
<dbReference type="HOGENOM" id="CLU_052560_0_0_1"/>
<dbReference type="InParanoid" id="P01106"/>
<dbReference type="KO" id="K04377"/>
<dbReference type="PhylomeDB" id="P01106"/>
<dbReference type="TreeFam" id="TF106001"/>
<dbReference type="BioCyc" id="MetaCyc:ENSG00000136997-MONOMER"/>
<dbReference type="PathwayCommons" id="P01106"/>
<dbReference type="Reactome" id="R-HSA-1362277">
<property type="pathway name" value="Transcription of E2F targets under negative control by DREAM complex"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-2122947">
<property type="pathway name" value="NOTCH1 Intracellular Domain Regulates Transcription"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-2173796">
<property type="pathway name" value="SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-2644606">
<property type="pathway name" value="Constitutive Signaling by NOTCH1 PEST Domain Mutants"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-2894862">
<property type="pathway name" value="Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-4411364">
<property type="pathway name" value="Binding of TCF/LEF:CTNNB1 to target gene promoters"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-5687128">
<property type="pathway name" value="MAPK6/MAPK4 signaling"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-5689880">
<property type="pathway name" value="Ub-specific processing proteases"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-6785807">
<property type="pathway name" value="Interleukin-4 and Interleukin-13 signaling"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-69202">
<property type="pathway name" value="Cyclin E associated events during G1/S transition"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-69656">
<property type="pathway name" value="Cyclin A:Cdk2-associated events at S phase entry"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-8866911">
<property type="pathway name" value="TFAP2 (AP-2) family regulates transcription of cell cycle factors"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-8951430">
<property type="pathway name" value="RUNX3 regulates WNT signaling"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-9018519">
<property type="pathway name" value="Estrogen-dependent gene expression"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-9616222">
<property type="pathway name" value="Transcriptional regulation of granulopoiesis"/>
</dbReference>
<dbReference type="SignaLink" id="P01106"/>
<dbReference type="SIGNOR" id="P01106"/>
<dbReference type="BioGRID-ORCS" id="4609">
<property type="hits" value="757 hits in 898 CRISPR screens"/>
</dbReference>
<dbReference type="ChiTaRS" id="MYC">
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="EvolutionaryTrace" id="P01106"/>
<dbReference type="GeneWiki" id="Myc"/>
<dbReference type="GenomeRNAi" id="4609"/>
<dbReference type="Pharos" id="P01106">
<property type="development level" value="Tbio"/>
</dbReference>
<dbReference type="PRO" id="PR:P01106"/>
<dbReference type="Proteomes" id="UP000005640">
<property type="component" value="Chromosome 8"/>
</dbReference>
<dbReference type="RNAct" id="P01106">
<property type="molecule type" value="protein"/>
</dbReference>
<dbReference type="Bgee" id="ENSG00000136997">
<property type="expression patterns" value="Expressed in thoracic mammary gland and 232 other tissues"/>
</dbReference>
<dbReference type="ExpressionAtlas" id="P01106">
<property type="expression patterns" value="baseline and differential"/>
</dbReference>
<dbReference type="Genevisible" id="P01106">
<property type="organism ID" value="HS"/>
</dbReference>
<dbReference type="GO" id="GO:0042025">
<property type="term" value="C:host cell nucleus"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="InterPro"/>
</dbReference>
<dbReference type="GO" id="GO:0000790">
<property type="term" value="C:nuclear chromatin"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0005730">
<property type="term" value="C:nucleolus"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0005654">
<property type="term" value="C:nucleoplasm"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0005634">
<property type="term" value="C:nucleus"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0032991">
<property type="term" value="C:protein-containing complex"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0033613">
<property type="term" value="F:activating transcription factor binding"/>
<property type="evidence" value="ECO:0000353"/>
<property type="project" value="CAFA"/>
</dbReference>
<dbReference type="GO" id="GO:0001046">
<property type="term" value="F:core promoter sequence-specific DNA binding"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="ARUK-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0003677">
<property type="term" value="F:DNA binding"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0001228">
<property type="term" value="F:DNA-binding transcription activator activity, RNA polymerase II-specific"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="NTNU_SB"/>
</dbReference>
<dbReference type="GO" id="GO:0003700">
<property type="term" value="F:DNA-binding transcription factor activity"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0000981">
<property type="term" value="F:DNA-binding transcription factor activity, RNA polymerase II-specific"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0001227">
<property type="term" value="F:DNA-binding transcription repressor activity, RNA polymerase II-specific"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0070888">
<property type="term" value="F:E-box binding"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0046983">
<property type="term" value="F:protein dimerization activity"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="InterPro"/>
</dbReference>
<dbReference type="GO" id="GO:0044877">
<property type="term" value="F:protein-containing complex binding"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0070491">
<property type="term" value="F:repressing transcription factor binding"/>
<property type="evidence" value="ECO:0000353"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0000978">
<property type="term" value="F:RNA polymerase II cis-regulatory region sequence-specific DNA binding"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="NTNU_SB"/>
</dbReference>
<dbReference type="GO" id="GO:0008134">
<property type="term" value="F:transcription factor binding"/>
<property type="evidence" value="ECO:0000353"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:1904837">
<property type="term" value="P:beta-catenin-TCF complex assembly"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0001658">
<property type="term" value="P:branching involved in ureteric bud morphogenesis"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0007050">
<property type="term" value="P:cell cycle arrest"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0006879">
<property type="term" value="P:cellular iron ion homeostasis"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0006974">
<property type="term" value="P:cellular response to DNA damage stimulus"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0035690">
<property type="term" value="P:cellular response to drug"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0071456">
<property type="term" value="P:cellular response to hypoxia"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="CAFA"/>
</dbReference>
<dbReference type="GO" id="GO:0034644">
<property type="term" value="P:cellular response to UV"/>
<property type="evidence" value="ECO:0000270"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0006338">
<property type="term" value="P:chromatin remodeling"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0051276">
<property type="term" value="P:chromosome organization"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0019221">
<property type="term" value="P:cytokine-mediated signaling pathway"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0006112">
<property type="term" value="P:energy reserve metabolic process"/>
<property type="evidence" value="ECO:0000303"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0070371">
<property type="term" value="P:ERK1 and ERK2 cascade"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="CAFA"/>
</dbReference>
<dbReference type="GO" id="GO:0044346">
<property type="term" value="P:fibroblast apoptotic process"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0000082">
<property type="term" value="P:G1/S transition of mitotic cell cycle"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0000165">
<property type="term" value="P:MAPK cascade"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0043066">
<property type="term" value="P:negative regulation of apoptotic process"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0051782">
<property type="term" value="P:negative regulation of cell division"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0048147">
<property type="term" value="P:negative regulation of fibroblast proliferation"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0045656">
<property type="term" value="P:negative regulation of monocyte differentiation"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0032873">
<property type="term" value="P:negative regulation of stress-activated MAPK cascade"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0000122">
<property type="term" value="P:negative regulation of transcription by RNA polymerase II"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0007219">
<property type="term" value="P:Notch signaling pathway"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0015671">
<property type="term" value="P:oxygen transport"/>
<property type="evidence" value="ECO:0000303"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0008284">
<property type="term" value="P:positive regulation of cell population proliferation"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="CAFA"/>
</dbReference>
<dbReference type="GO" id="GO:0043280">
<property type="term" value="P:positive regulation of cysteine-type endopeptidase activity involved in apoptotic process"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:2000573">
<property type="term" value="P:positive regulation of DNA biosynthetic process"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:1905643">
<property type="term" value="P:positive regulation of DNA methylation"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0050679">
<property type="term" value="P:positive regulation of epithelial cell proliferation"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0048146">
<property type="term" value="P:positive regulation of fibroblast proliferation"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0010628">
<property type="term" value="P:positive regulation of gene expression"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="CAFA"/>
</dbReference>
<dbReference type="GO" id="GO:0002053">
<property type="term" value="P:positive regulation of mesenchymal cell proliferation"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0090096">
<property type="term" value="P:positive regulation of metanephric cap mesenchymal cell proliferation"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:2001022">
<property type="term" value="P:positive regulation of response to DNA damage stimulus"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0051973">
<property type="term" value="P:positive regulation of telomerase activity"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0045944">
<property type="term" value="P:positive regulation of transcription by RNA polymerase II"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="NTNU_SB"/>
</dbReference>
<dbReference type="GO" id="GO:0045893">
<property type="term" value="P:positive regulation of transcription, DNA-templated"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0016579">
<property type="term" value="P:protein deubiquitination"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0032986">
<property type="term" value="P:protein-DNA complex disassembly"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="CAFA"/>
</dbReference>
<dbReference type="GO" id="GO:0010468">
<property type="term" value="P:regulation of gene expression"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="MGI"/>
</dbReference>
<dbReference type="GO" id="GO:1904672">
<property type="term" value="P:regulation of somatic stem cell population maintenance"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0032204">
<property type="term" value="P:regulation of telomere maintenance"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0006357">
<property type="term" value="P:regulation of transcription by RNA polymerase II"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0042493">
<property type="term" value="P:response to drug"/>
<property type="evidence" value="ECO:0000270"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0010332">
<property type="term" value="P:response to gamma radiation"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0070848">
<property type="term" value="P:response to growth factor"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="CDD" id="cd00083">
<property type="entry name" value="HLH"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="DisProt" id="DP00260"/>
<dbReference type="Gene3D" id="4.10.280.10">
<property type="match status" value="1"/>
</dbReference>
<dbReference type="IDEAL" id="IID00012"/>
<dbReference type="InterPro" id="IPR011598">
<property type="entry name" value="bHLH_dom"/>
</dbReference>
<dbReference type="InterPro" id="IPR036638">
<property type="entry name" value="HLH_DNA-bd_sf"/>
</dbReference>
<dbReference type="InterPro" id="IPR003327">
<property type="entry name" value="Myc-LZ"/>
</dbReference>
<dbReference type="InterPro" id="IPR002418">
<property type="entry name" value="Tscrpt_reg_Myc"/>
</dbReference>
<dbReference type="InterPro" id="IPR012682">
<property type="entry name" value="Tscrpt_reg_Myc_N"/>
</dbReference>
<dbReference type="Pfam" id="PF00010">
<property type="entry name" value="HLH"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Pfam" id="PF02344">
<property type="entry name" value="Myc-LZ"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Pfam" id="PF01056">
<property type="entry name" value="Myc_N"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PIRSF" id="PIRSF001705">
<property type="entry name" value="Myc_protein"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PRINTS" id="PR00044">
<property type="entry name" value="LEUZIPPRMYC"/>
</dbReference>
<dbReference type="SMART" id="SM00353">
<property type="entry name" value="HLH"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SUPFAM" id="SSF47459">
<property type="entry name" value="SSF47459"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS50888">
<property type="entry name" value="BHLH"/>
<property type="match status" value="1"/>
</dbReference>
<proteinExistence type="evidence at protein level"/>
<keyword id="KW-0002">3D-structure</keyword>
<keyword id="KW-0007">Acetylation</keyword>
<keyword id="KW-0010">Activator</keyword>
<keyword id="KW-0025">Alternative splicing</keyword>
<keyword id="KW-0160">Chromosomal rearrangement</keyword>
<keyword id="KW-0238">DNA-binding</keyword>
<keyword id="KW-0325">Glycoprotein</keyword>
<keyword id="KW-1017">Isopeptide bond</keyword>
<keyword id="KW-0539">Nucleus</keyword>
<keyword id="KW-0597">Phosphoprotein</keyword>
<keyword id="KW-0621">Polymorphism</keyword>
<keyword id="KW-0656">Proto-oncogene</keyword>
<keyword id="KW-1185">Reference proteome</keyword>
<keyword id="KW-0804">Transcription</keyword>
<keyword id="KW-0805">Transcription regulation</keyword>
<keyword id="KW-0832">Ubl conjugation</keyword>
<feature type="chain" description="Myc proto-oncogene protein" id="PRO_0000127293">
<location>
<begin position="1"/>
<end position="439"/>
</location>
</feature>
<feature type="domain" description="bHLH" evidence="12">
<location>
<begin position="354"/>
<end position="406"/>
</location>
</feature>
<feature type="region of interest" description="Leucine-zipper">
<location>
<begin position="413"/>
<end position="434"/>
</location>
</feature>
<feature type="compositionally biased region" description="Poly-Gln">
<location>
<begin position="33"/>
<end position="37"/>
</location>
</feature>
<feature type="compositionally biased region" description="Poly-Gly">
<location>
<begin position="88"/>
<end position="91"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="6 8">
<location>
<position position="6"/>
</location>
</feature>
<feature type="modified residue" description="Phosphothreonine; by RAF; in vitro" evidence="35">
<location>
<position position="8"/>
</location>
</feature>
<feature type="modified residue" description="Phosphothreonine; by GSK3; alternate" evidence="3 4 7 8 13 19 34">
<location>
<position position="58"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine; by DYRK2, GSK3 and CDK2" evidence="4 7 8 13 19 23 25 27 34">
<location>
<position position="62"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="4 8">
<location>
<position position="71"/>
</location>
</feature>
<feature type="modified residue" description="N6-acetyllysine; by PCAF; alternate" evidence="16">
<location>
<position position="143"/>
</location>
</feature>
<feature type="modified residue" description="N6-acetyllysine; alternate" evidence="5">
<location>
<position position="148"/>
</location>
</feature>
<feature type="modified residue" description="N6-acetyllysine; by PCAF" evidence="16">
<location>
<position position="157"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="6">
<location>
<position position="161"/>
</location>
</feature>
<feature type="modified residue" description="N6-acetyllysine; by PCAF" evidence="16">
<location>
<position position="275"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="8">
<location>
<position position="293"/>
</location>
</feature>
<feature type="modified residue" description="N6-acetyllysine; by PCAF" evidence="16">
<location>
<position position="317"/>
</location>
</feature>
<feature type="modified residue" description="N6-acetyllysine; by PCAF" evidence="16">
<location>
<position position="323"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine; by PIM2; in vitro" evidence="11">
<location>
<position position="329"/>
</location>
</feature>
<feature type="modified residue" description="N6-acetyllysine; by PCAF" evidence="16">
<location>
<position position="371"/>
</location>
</feature>
<feature type="glycosylation site" description="O-linked (GlcNAc) threonine; alternate" id="CAR_000033" evidence="32">
<location>
<position position="58"/>
</location>
</feature>
<feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)" evidence="9">
<location>
<position position="52"/>
</location>
</feature>
<feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate" evidence="9">
<location>
<position position="143"/>
</location>
</feature>
<feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate" evidence="9">
<location>
<position position="148"/>
</location>
</feature>
<feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)" evidence="9">
<location>
<position position="298"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 2." id="VSP_037813" evidence="38">
<original>M</original>
<variation>MDFFRVVENQQPPATM</variation>
<location>
<position position="1"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs4645959." id="VAR_016327" evidence="37">
<original>N</original>
<variation>S</variation>
<location>
<position position="11"/>
</location>
</feature>
<feature type="sequence variant" description="In a Burkitt lymphoma symple; dbSNP:rs121918684." id="VAR_063384" evidence="31 33">
<original>E</original>
<variation>D</variation>
<location>
<position position="39"/>
</location>
</feature>
<feature type="sequence variant" description="In a Burkitt lymphoma sample; dbSNP:rs28933407." id="VAR_063385" evidence="33">
<original>P</original>
<variation>S</variation>
<location>
<position position="57"/>
</location>
</feature>
<feature type="sequence variant" description="In a Burkitt lymphoma sample; dbSNP:rs121918685." id="VAR_063386" evidence="33">
<original>P</original>
<variation>A</variation>
<location>
<position position="59"/>
</location>
</feature>
<feature type="sequence variant" description="In a Burkitt lymphoma sample; dbSNP:rs121918683." id="VAR_063387" evidence="33">
<original>N</original>
<variation>T</variation>
<location>
<position position="86"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs4645960." id="VAR_016328" evidence="37">
<original>G</original>
<variation>C</variation>
<location>
<position position="160"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs4645961." id="VAR_016329" evidence="37">
<original>V</original>
<variation>I</variation>
<location>
<position position="170"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs4645968." id="VAR_016330" evidence="37">
<original>A</original>
<variation>V</variation>
<location>
<position position="322"/>
</location>
</feature>
<feature type="mutagenesis site" description="Impairs interaction with FBXW7 and subsequent degradation by the proteasome. Normal inhibition of Ras-induced senescence." evidence="13 19 23 25">
<original>T</original>
<variation>A</variation>
<location>
<position position="58"/>
</location>
</feature>
<feature type="mutagenesis site" description="Impairs interaction with FBXW7 and subsequent degradation by the proteasome. Impaired inhibition of Ras-induced senescence. Abolishes phosphorylation by DYRK2, and subsequent phosphorylation by GSK3B at Thr-58." evidence="13 19 23 25 27">
<original>S</original>
<variation>A</variation>
<location>
<position position="62"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 5; no nucleotide entry." ref="5" evidence="39">
<original>SF</original>
<variation>TI</variation>
<location>
<begin position="6"/>
<end position="7"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 5; no nucleotide entry." ref="5" evidence="39">
<original>R</original>
<variation>K</variation>
<location>
<position position="10"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 5; no nucleotide entry." ref="5" evidence="39">
<original>L</original>
<variation>LL</variation>
<location>
<position position="56"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 7; CAA25288." ref="7" evidence="39">
<original>S</original>
<variation>P</variation>
<location>
<position position="62"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 5; no nucleotide entry." ref="5" evidence="39">
<original>G</original>
<variation>D</variation>
<location>
<position position="88"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 5; no nucleotide entry." ref="5" evidence="39">
<original>S</original>
<variation>N</variation>
<location>
<position position="92"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 5; no nucleotide entry." ref="5" evidence="39">
<original>S</original>
<variation>N</variation>
<location>
<position position="114"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 5; no nucleotide entry." ref="5" evidence="39">
<original>D</original>
<variation>G</variation>
<location>
<position position="120"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 5; no nucleotide entry." ref="5" evidence="39">
<original>C</original>
<variation>S</variation>
<location>
<position position="171"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 5; no nucleotide entry." ref="5" evidence="39">
<original>S</original>
<variation>R</variation>
<location>
<position position="203"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 5; no nucleotide entry." ref="5" evidence="39">
<original>S</original>
<variation>A</variation>
<location>
<position position="230"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 5; no nucleotide entry." ref="5" evidence="39">
<original>L</original>
<variation>F</variation>
<location>
<position position="240"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 5; no nucleotide entry." ref="5" evidence="39">
<original>P</original>
<variation>S</variation>
<location>
<position position="245"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="98"/>
<end position="103"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="104"/>
<end position="106"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="351"/>
<end position="378"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="382"/>
<end position="384"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="392"/>
<end position="435"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 7; BAA01374." ref="7" evidence="39">
<original>D</original>
<variation>N</variation>
<location sequence="P01106-2">
<position position="2"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 7; BAA01374." ref="7" evidence="39">
<original>V</original>
<variation>E</variation>
<location sequence="P01106-2">
<position position="6"/>
</location>
</feature>
<evidence key="1" type="ECO:0000244">
<source>
<dbReference type="PDB" id="6E16"/>
</source>
</evidence>
<evidence key="2" type="ECO:0000244">
<source>
<dbReference type="PDB" id="6G6K"/>
</source>
</evidence>
<evidence key="3" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="17081983"/>
</source>
</evidence>
<evidence key="4" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="18669648"/>
</source>
</evidence>
<evidence key="5" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="19608861"/>
</source>
</evidence>
<evidence key="6" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="20068231"/>
</source>
</evidence>
<evidence key="7" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="21406692"/>
</source>
</evidence>
<evidence key="8" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="23186163"/>
</source>
</evidence>
<evidence key="9" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="28112733"/>
</source>
</evidence>
<evidence key="10" type="ECO:0000250"/>
<evidence key="11" type="ECO:0000250">
<source>
<dbReference type="UniProtKB" id="P01108"/>
</source>
</evidence>
<evidence key="12" type="ECO:0000255">
<source>
<dbReference type="PROSITE-ProRule" id="PRU00981"/>
</source>
</evidence>
<evidence key="13" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15103331"/>
</source>
</evidence>
<evidence key="14" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15674325"/>
</source>
</evidence>
<evidence key="15" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15723054"/>
</source>
</evidence>
<evidence key="16" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16126174"/>
</source>
</evidence>
<evidence key="17" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="17308053"/>
</source>
</evidence>
<evidence key="18" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="17311883"/>
</source>
</evidence>
<evidence key="19" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="17558397"/>
</source>
</evidence>
<evidence key="20" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="17632056"/>
</source>
</evidence>
<evidence key="21" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="17873522"/>
</source>
</evidence>
<evidence key="22" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="18035408"/>
</source>
</evidence>
<evidence key="23" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="19966300"/>
</source>
</evidence>
<evidence key="24" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="2069907"/>
</source>
</evidence>
<evidence key="25" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="20713526"/>
</source>
</evidence>
<evidence key="26" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="2166998"/>
</source>
</evidence>
<evidence key="27" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="22307329"/>
</source>
</evidence>
<evidence key="28" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="24940000"/>
</source>
</evidence>
<evidence key="29" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="25775507"/>
</source>
</evidence>
<evidence key="30" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="25956029"/>
</source>
</evidence>
<evidence key="31" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="6419122"/>
</source>
</evidence>
<evidence key="32" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="7642555"/>
</source>
</evidence>
<evidence key="33" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="8220424"/>
</source>
</evidence>
<evidence key="34" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="8386367"/>
</source>
</evidence>
<evidence key="35" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="9315742"/>
</source>
</evidence>
<evidence key="36" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="9680483"/>
</source>
</evidence>
<evidence key="37" type="ECO:0000269">
<source ref="11"/>
</evidence>
<evidence key="38" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="15489334"/>
</source>
</evidence>
<evidence key="39" type="ECO:0000305"/>
<sequence length="439" mass="48804" checksum="ED5C028029A4C5D1" modified="1987-08-13" version="1">MPLNVSFTNRNYDLDYDSVQPYFYCDEEENFYQQQQQSELQPPAPSEDIWKKFELLPTPPLSPSRRSGLCSPSYVAVTPFSLRGDNDGGGGSFSTADQLEMVTELLGGDMVNQSFICDPDDETFIKNIIIQDCMWSGFSAAAKLVSEKLASYQAARKDSGSPNPARGHSVCSTSSLYLQDLSAAASECIDPSVVFPYPLNDSSSPKSCASQDSSAFSPSSDSLLSSTESSPQGSPEPLVLHEETPPTTSSDSEEEQEDEEEIDVVSVEKRQAPGKRSESGSPSAGGHSKPPHSPLVLKRCHVSTHQHNYAAPPSTRKDYPAAKRVKLDSVRVLRQISNNRKCTSPRSSDTEENVKRRTHNVLERQRRNELKRSFFALRDQIPELENNEKAPKVVILKKATAYILSVQAEEQKLISEEDLLRKRREQLKHKLEQLRNSCA</sequence>
</entry>
<copyright>
Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
Distributed under the Creative Commons Attribution (CC BY 4.0) License
</copyright>
</uniprot>

